GLIOSARCOMA
Clinical trials for GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new GLIOSARCOMA trials appear
Sign up with your email to follow new studies for GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy duo takes on deadliest brain tumor
Disease control CompletedThis study tested a new treatment for a fast-growing type of brain cancer called glioblastoma that doesn't respond well to standard chemotherapy. About 159 patients received either the usual treatment (radiation plus chemo) or radiation plus two immunotherapy drugs (ipilimumab an…
Matched conditions: GLIOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New combo therapy shows promise in tough brain cancer trial
Disease control CompletedThis study tested whether adding whole brain radiation and a drug called plerixafor to standard chemotherapy can help people with a fast-growing brain tumor called glioblastoma. The trial included 21 newly diagnosed patients. The goal was to see if this combination could slow tum…
Matched conditions: GLIOSARCOMA
Phase: PHASE2 • Sponsor: Lawrence D Recht • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Immunotherapy combo shows promise in tough brain cancer trial
Disease control CompletedThis study tested adding the immunotherapy drug atezolizumab to standard chemotherapy and radiation for people with newly diagnosed glioblastoma, an aggressive brain cancer. The goal was to see if the combination is safe and helps patients live longer. The trial enrolled 60 parti…
Matched conditions: GLIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Second radiation blast shows promise for aggressive brain cancer
Disease control CompletedThis study looked at whether giving a second round of radiation is safe for people whose glioblastoma (a fast-growing brain tumor) has come back after standard treatment. Seventeen adults aged 18 to 50 with good overall health took part. The goal was to find the highest safe dose…
Matched conditions: GLIOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Blood test may predict brain tumor treatment success
Knowledge-focused CompletedThis study examined 47 adults with newly diagnosed glioblastoma or gliosarcoma to see if changes in immune cells in the blood could predict how well they respond to a combination of immunotherapy drugs (ipilimumab and nivolumab) plus standard chemotherapy. Participants had alread…
Matched conditions: GLIOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC